Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enzyme-inducing anticonvulsants improve tolerability of CCI-779 in patients with CNS tumors

Dec. 5, 2002

Improved tolerability of PZA in glioblastoma multiforme patients receiving anticonvulsants

Dec. 5, 2002

EMD-121794 reported to be well tolerated in patients with malignant gliomas

Dec. 5, 2002

Thalidomide plus temozolomide in malignant gliomas

Dec. 5, 2002

Good tolerability profile reported for tetracycline COL-3 in high-grade glioma

Dec. 5, 2002

Mercury Therapeutics licenses oncology target from Mass General

Dec. 4, 2002

Axcan receives approvable letter for Photofrin

Dec. 4, 2002

Enrollment completed in phase III trial of ABI-007

Dec. 4, 2002

Taxotere approved for first-line therapy in NSCLC

Dec. 4, 2002

Human Genome Sciences and Kirin announce license agreement

Dec. 4, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...